Skip to main content
. 2013 Jan 24;8(1):e54824. doi: 10.1371/journal.pone.0054824

Figure 4. Percentage of PDL-1 expression among splenic CD33+CD14HLA-DR+ cells.

Figure 4

Ref. = reference group made of patients with serous cystadenoma (open dots) and of patients with splenic non-neoplastic lesions; PaCa = Ductal adenocarcinoma; NETs = Neuroendocrine tumors. Kruskal-Wallis test: p = 0.046.